Drug Profile
ICT 111
Alternative Names: Cancer stem cell antigen vaccine; ICT-111Latest Information Update: 16 Dec 2013
Price :
$50
*
At a glance
- Originator ImmunoCellular Therapeutics
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants; Stem cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glioblastoma